Women's experiences of changes in related men's impulsivity and domestic violence following men's participation in the ReINVEST clinical trial

男性参与 ReINVEST 临床试验后,女性对相关男性冲动性和家庭暴力行为变化的体验

阅读:1

Abstract

BACKGROUND: Impulsivity, a behaviour often associated with reactive violence to perceived provocation or stress is a key risk factor for Domestic Violence (DV) perpetration. This study explores the experiences of women on related men's changes in impulsivity and DV following men's participation in the ReINVEST clinical trial that investigated whether the commonly used antidepressant sertraline would reduce impulsivity and domestic violence. METHODS: The study conducted in-depth interviews with 27 women ex(partners) and family members living in New South Wales, Australia. Critical Realism and Self-Determination Theory (SDT) underpinned the analysis and interpretation of findings. RESULTS: Most women (92.3%, n = 24) reported some or significant changes in impulsivity and DV or intimate partner violence (IPV) following the participation of related men in the trial. Many changes were reported at the individual (e.g., self-regulation), partner or family (e.g., feeling safer), and social levels (e.g., employment). Analysis using critical realism and SDT identified three themes (Determination to change, Enabling environment, and Continuum of changes) that illustrated the underlying mechanisms and causal explanations of the changes women experienced among themselves and the trial participants. CONCLUSIONS: The experiences of women revealed the benefit of antidepressant sertraline in reducing impulsivity and DV or IPV when supported with other interventions (e.g., counselling and follow-up support by clinicians). The behaviour change processes described using critical realism and Self-Determination Theory (SDT) demonstrated the potential of SDT-grounded approaches in reducing impulsivity and its associated effects on intimate partner violence (IPV) or domestic violence (DV). TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry, ACTRN12613000442707, registered on 18/04/2013.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。